1 |
Fabrega E, Orive A, Garcia-Unzueta M, Amado JA, Casafont F, Pons-Romero F. Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand system in the early post-operative period of liver transplantation. Clin Transplant. 2006; 20:383-8. |
FI: |
1,887 |
2 |
Garcia-Unzueta MT, Martinez-Taboada VM, Amado-Senaris JA, Rodriguez-Valverde V. Plasma adrenomedullin levels in patients with polymyalgia rheumatica and giant cell arteritis. Clin Exp Rheumatol. 2006; 24:6-9. |
FI: |
2,366 |
3 |
Garcia-Unzueta MT, Pesquera C, Calzada E, De la Mora A, Munoz P, Llorca J, Morchon N, Fernandez-Gonzalez MD, Amado JA. Blood-soluble Fas Levels are Increased in Type 2 Diabetic Patients with Peripheral Vascular Disease. Horm Metab Res. 2006; 38:673-7. |
FI: |
2,049 |
4 |
González-Gay MA, García-Unzueta MT, de Matías JM, González-Juanetey C, García-Porrúa C, Sanchez-Andrade A, Martín J, LLorca J. Influence of anti-TNF-α infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthitris. Clin Exper Rheumatol. 2006; 24:373-379. |
FI: |
2,366 |
5 |
Gutierrez-Santiago M, Garcia-Unzueta M, Amado JA, Gonzalez-Macias J, Riancho JA. Electrolyte disorders following colonic cleansing for imaging studies. Med Clin (Barc). 2006; 126:161-4. |
FI: |
1,074 |
6 |
Herran A, Ramirez ML, Carrera M, Garcia-Unzueta MT, Sierra-Biddle D, Rodriguez-Cabo B, Ayestaran A, Hoyuela F, Vazquez-Barquero JL. Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels. J Clin Psychopharmacol. 2006; 26:538-40. |
FI: |
5,145 |
7 |
Rojas D, Blanco O, Elicegui I, García-Unzueta MT. Aspectos funcionales para el desarrollo e implantación de un Gestor de Peticiones de Pruebas Diagnósticas Hospitalarias. Informática y Salud (I+S). 2006, 58:22-25. |
FI: |
No |